Alexandre Di Paolo

Alexandre Di Paolo

Company: TriLink BioTechnologies

Job title: Senior Business Development Manager

Seminars:

mRNA Modifications that Matter: Modified Uridine as a Therapeutic Tool 10:45 am

Read more

day: Day Two

mRNA Modifications that Matter: Modified Uridine as a Therapeutic Tool 10:45 am

In vitro transcribed (IVT) mRNA has become an effective and scalable therapeutic modality for a wide range of disease indications It has been shown that modifications to wild-type uridine may improve the efficacy of these therapeutics To aid in the synthesis of these compounds, TriLink is developing an extensive platform to manufacture modified uridine and…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.